Advanced search
Publication Cover
Future Rare Diseases Volume 4, 2023 - Issue 1
Submit an article Journal homepage
828
Views
0
CrossRef citations to date
0
Altmetric
Plain Language Summary of Publication

The effects of garetosmab in people with fibrodysplasia ossificans progressiva (FOP): A plain language summary of the LUMINA-1 study

Maja Di Rocco1 Department of Pediatrics, Unit of Rare Diseases, IRCCS Istituto Giannina Gaslini, Genoa, Italy
,
Robert J Pignolo2 Department of Medicine, Mayo Clinic, Rochester, MN, USA
,
Richard Keen3 Centre for Metabolic Bone Disease, Royal National Orthopaedic Hospital NHS Trust, London, UK
,
Dushyanth Srinivasan4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Scott J Mellis4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Michelle Davis5 International Fibrodysplasia Ossificans Progressiva Association, North Kansas City, MO, USA
,
Philippe Orcel6 Department of Rheumatology - DMU Locomotion, Assistance Publique – Hôpitaux de Paris, Paris, France;7 INSERM Université Paris Cité, Paris, France
,
Christian Roux8 Department of Rheumatology, Cochin Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
,
Małgorzata Szczepanek9 Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów University, Rzeszów, Podkarpackie, Poland
,
Javier Bachiller-Corral10 Department of Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain
,
Angela M Cheung11 University Health Network, University of Toronto, Toronto, ON, Canada
,
Kathryn M Dahir12 Vanderbilt University Medical Center, Program for Metabolic Bone Disorders, Nashville, TN, USA
,
Mona Al Mukaddam13 Departments of Orthopaedics, Medicine & the Center for Research in FOP & Related Disorders, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
,
Anita Boyapati4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Kusha Mohammadi4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Aris N Economides4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Robert J Sanchez4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Dinko Gonzalez Trotter4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Susan Rhee4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Gary A Herman4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
Richard DelGizzi4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
George D Yancopoulos4 Regeneron Pharmaceuticals, Tarrytown, NY, USA
,
E Marelise W Eekhoff14 Department of Internal Medicine, Section Endocrinology & Metabolism, Amsterdam University Medical Centers (UMC), Vrije Universiteit, Amsterdam UMC Expert Center in Rare Bone Disease, Amsterdam Movement Sciences, Amsterdam, The Netherlands
&
Frederick S Kaplan13 Departments of Orthopaedics, Medicine & the Center for Research in FOP & Related Disorders, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
 show all
Article: FRD63 | Received 05 Dec 2023, Accepted 11 Mar 2024, Published online: 11 Apr 2024

Figures & data

This paper does not have figures.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.